Kewaunee Scientific (NASDAQ:KEQU) CEO Thomas David Hull III Sells 1,854 Shares of Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,854 shares of the stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $43.42, for a total value of $80,500.68. Following the completion of the transaction, the chief executive officer directly owned 39,719 shares of the company’s stock, valued at $1,724,598.98. This trade represents a 4.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.62, for a total value of $43,620.00.
• On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The stock was sold at an average price of $44.00, for a total value of $31,724.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.34, for a total transaction of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total transaction of $29,992.00.

Kewaunee Scientific Stock Up 3.6%

KEQU stock opened at $44.20 on Thursday. The firm’s 50-day moving average is $52.24 and its two-hundred day moving average is $45.34. The company has a market capitalization of $126.85 million, a price-to-earnings ratio of 10.70 and a beta of 0.68. Kewaunee Scientific Corporation has a 52 week low of $30.33 and a 52 week high of $71.33. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88.

Kewaunee Scientific (NASDAQ:KEQU) last released its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The firm had revenue of $71.10 million during the quarter.

Hedge Funds Weigh In On Kewaunee Scientific

Several hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Punch & Associates Investment Management Inc. acquired a new position in shares of Kewaunee Scientific during the first quarter valued at about $788,000. American Century Companies Inc. raised its holdings in Kewaunee Scientific by 43.4% in the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after acquiring an additional 14,889 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Kewaunee Scientific by 125.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock worth $764,000 after acquiring an additional 10,803 shares during the period. OMERS ADMINISTRATION Corp acquired a new position in shares of Kewaunee Scientific in the first quarter valued at $284,000. Finally, Mink Brook Asset Management LLC bought a new position in Kewaunee Scientific in the second quarter worth $370,000. Institutional investors own 32.69% of the company’s stock.

Analyst Ratings Changes

Separately, Wall Street Zen raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.